Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Open: May 25, 10:07 AM 2012  
PRGO HLF AUXL PBH USNA LFVN 
 
 
  NYSE  7,554  1.695  Index Moved Up 



Processing
Collecting data for AXRX

Amexdrug quote and profile

    
1.25
  
OTC EQUITY
 0.00   No Change   0.00%  

Diversification Suggestion

Use Amexdrug to offset short term systematic risk or to hedge overall market volatility. The stock experiences no pattern. Wait for more market signals and watch out for any hype

1 Month Beta ..........

0.0
Unless we do not have data at the moment the returns on S&P 500 and Amexdrug are completely uncorrelated
Amexdrug Corporation not significant Beta
AXRX United States OTC BB
Amexdrug Corporation
 
Trade Amexdrug
Current Valuation10.74 M
Shares Outstanding8.47 M
Revenue11.75 M
Gross Profit995.75 K
 United States NYSE   0.02 % Macroaxis: 0.02 Moved Up  
 
 United States SP 500   0.01 % Macroaxis: 0.01 Moved Up  
 
 thisGreen AXRX AXRX.OB agains markets  0.00 % No Change  
 United States NASDAQ   0.05 % Macroaxis: 0.05 Moved Down  
 

Amexdrug Leadership

Jack Amin Chairman, CEO and President VP, CFO, Chief Accounting Officer, Treasurer, CEO of Allied Med Inc and President of Allied Med Inc, Secretary and Director of Allied Med Inc

Amexdrug Price and Market Media

The median price of Amexdrug for the period between Wed, Apr 25, 2012 and Fri, May 25, 2012 is 1.25 with a coefficient of variation of 0.0. The daily time series for the period is distributed with a sample standard deviation of 0.0, arithmetic mean of 1.25, and mean deviation of 0.0. The Stock did not receive any noticable media coverage during the period.
Amexdrug         Market
Price Growth (%)
 
Timeline

Amexdrug Summary

Amexdrug Corporation [AXRX] is traded as part of a regulated electronic trading service offered by the NASD. The company currently falls under 'Micro-Cap' category with current market capitalization of 10.59 M. Amexdrug Corporation operates under Healthcare sector and is part of Drug Related Products industry. This company has 8.47 M outstanding shares.

Amexdrug Liquidity

AMEXDRUG CP has accumulated about 133.26 K in cash with (23.62 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
The company has accumulated 289.5 K in total debt with debt to equity ratio (D/E) of 0.64 which is about averege as compared to similar companies. Amexdrug Corporation has Current Ratio of 1.43 which is within standard range for the sector.

Discuss Amexdrug quote and profile

       
       
    
    
Amexdrug
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Amexdrug Corporation has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    

Promote Amexdrug

    
Follow Amexdrug with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Amexdrug to your reader
 
Get social with Amexdrug
 Get social with Amexdrug 
Share Toggle social options for Amexdrug
    

Add Amexdrug to Your Portfolio

    
Sign in to add this equity to your portfolios   
  
 
    

Amexdrug Research Report

    
    

Amexdrug Directors

Rodney Barron Independent Director
Behrooz Meimand Independent Director



 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting